Arrhythmia Disorders News

The antiarrhythmic benefits of empagliflozin in patients with and without diabetes may be explained by the SGLT2 inhibitor’s ability to improve left atrial strain reservoir and contraction phase values, researchers reported.

The novel ANTWERP score demonstrated good predictive value in identifying patients whose heart failure symptoms would improve after ablation for atrial fibrillation, a speaker reported.

In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.

Assessing safety and effectiveness of the PulseSelect PFA System (Medtronic) for treatment of atrial fibrillation.

The American College of Cardiology Scientific Session featured three late-breaking clinical trials of particular interest to the sports cardiology and hypertrophic cardiomyopathy communities.

Statin therapy may improve risk for stroke or transient ischemic attack among patients with atrial fibrillation compared with nonuse, regardless of concomitant anticoagulant use, a speaker reported.

Adults with atrial fibrillation and vascular dementia have a higher risk for stroke, rehospitalization and mortality compared with those with AF and Alzheimer’s disease, who have a higher risk for intercranial hemorrhage, data show.

High-powered chargers for electric vehicles are safe for people with implantable cardiac devices, with no evidence of clinically relevant electromagnetic interference, researchers reported.

Income and education had an inverse relationship with the risk for sudden cardiac death that was not explained by modifiable risk factors, researchers reported.

Adults who survived an out-of-hospital cardiac arrest and developed depression or anxiety within 1 year were 1.4 times more likely to die during follow-up compared with those without a mental health diagnosis, researchers reported.